통풍의 새로운 진단 분류 기준과 치료 지침
New Classification Criteria and Guideline for Management of Gout
0
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Gout is a chronic systemic metabolic disease characterized by recurrent attacks of inflammatory arthritis resulting from the precipitation of monosodium urate crystals, which has various clinical and pathological manifestations. The disease is associated with multiple comorbidities, an impaired quality of life, and a heavy economic burden. The incidence and prevalence of gout is increasing in many developed and developing countries, as in Korea. Gout is diagnosed by confirming monosodium urate crystals in the synovial fluid or affected tissue. If crystal documentation is unavailable, new gout classification criteria presented by the American College of Rheumatology and European League Against Rheumatism (ACR/EULAR) in 2015 can be applied. There are many guidelines for managing gout published in the United States, Japan, and Europe. However, there are no guidelines for the tailored management of gout for Korean patients. This review describes a new classification for the diagnosis of gout and management guidelines.
Abstract
Gout is a chronic systemic metabolic disease characterized by recurrent attacks of inflammatory arthritis resulting from the precipitation of monosodium urate crystals, which has various clinical and pathological manifestations. The disease is associated with multiple comorbidities, an impaired quality of life, and a heavy economic burden. The incidence and prevalence of gout is increasing in many developed and developing countries, as in Korea. Gout is diagnosed by confirming monosodium urate crystals in the synovial fluid or affected tissue. If crystal documentation is unavailable, new gout classification criteria presented by the American College of Rheumatology and European League Against Rheumatism (ACR/EULAR) in 2015 can be applied. There are many guidelines for managing gout published in the United States, Japan, and Europe. However, there are no guidelines for the tailored management of gout for Korean patients. This review describes a new classification for the diagnosis of gout and management guidelines.
참고문헌 (25)
- Roddy E, "Is gout associated with reduced quality of life? A case-control study", Rheumatology (Oxford), 46, pp.1441~1444 (2007)[DOI]
- Singh JA, "Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans", Ann Rheum Dis, 67, pp.1310~1316 (2008)
- Lee SJ, "Perceptions of disease and health-related quality of life among patients with gout", Rheumatology (Oxford), 48, pp.582~586 (2009)
- Choi HK, "Prevalence of the metabolic syndrome in patients with gout: the third national health and nutrition examination survey", Arthritis Rheum, 57, pp.109~115 (2007)[DOI]
- Choi HK, "Independent impact of gout on mortality and risk for coronary heart disease", Circulation, 116, pp.894~900 (2007)[DOI]
- Young Hee Rho, "The Prevalence of Metabolic Syndrome in Patients with Gout :A Multicenter Study", Journal of Korean Medical Science, 20(6), pp.1029~1033 (2005), 대한의학회
- Jae Hyun Jung, "Metabolic syndrome: prevalence and risk factors in Korean gout patients", The Korean Journal of Internal Medicine, 33(4), pp.815~822 (2018), 대한내과학회[DOI]
- Kuo CF, "Elevated risk of mortality among gout patients: a comparison with the national population in Taiwan", Joint Bone Spine, 78, pp.577~580 (2011)[DOI]
- 손경민, "통풍 환자의 요산억제제에 대한 순응도", 대한류마티스학회지, 17(2), pp.162~167 (2010), 대한류마티스학회
- Neogi T, "2015 gout classification criteria: an American college of rheumatology", European league against rheumatism collaborative initiative, 2015, pp.67, 2557~2568
- 이찬희, "국민건강보험공단 자료를 이용한 국내 거주 통풍 환자의 유병률과 특성에 관한 연구", 대한류마티스학회지, 18(2), pp.94~100 (2011), 대한류마티스학회
- Khanna D, "2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia", Arthritis Care Res (Hoboken), 64, pp.1431~1446 (2012)[DOI]
- Khanna D, "2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis", Arthritis Care Res (Hoboken), 64, pp.1447~1461 (2012)
- Yamanaka H, "Japanese guideline for the management of hyperuricemia and gout: second edition", Nucleosides Nucleotides Nucleic Acids, 30, pp.1018~1029 (2011)[DOI]
- Zhang W, "EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)", Ann Rheum Dis, 65, pp.1301~1311 (2006)[DOI]
- Zhang W, "EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT)", Ann Rheum Dis, 65, pp.1312~1324 (2006)[DOI]
- Wallace SL, "Preliminary criteria for the classification of the acute arthritis of primary gout", Arthritis Rheum, 20, pp.895~900 (1977)[DOI]
- Janssens HJ, "A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis", Arch Intern Med, 170, pp.1120~1126 (2010)
- Pelaez-Ballestas I, "Diagnosis of chronic gout: evaluating the American College of Rheumatology proposal, European league against rheumatism recommendations, and clinical judgment", J Rheumatol, 37, pp.1743~1748 (2010)[DOI]
- Malik A, "Clinical diagnostic criteria for gout: comparison with the gold standard of synovial fluid crystal analysis", J Clin Rheumatol, 15, pp.22~24 (2009)[DOI]
- Glazebrook KN, "Identification of intraarticular and periarticular uric acid crystals with dual-energy CT: initial evaluation", Radiology, 261, pp.516~524 (2011)[DOI]
- Naredo E, "Ultrasound-detected musculoskeletal urate crystal deposition: which joints and what findings should be assessed for diagnosing gout?", Ann Rheum Dis, 73, pp.1522~1528 (2014)
- Louthrenoo W, "Performance of the 2015 American College of Rheumatology", European league against rheumatism gout classification criteria in Thai patients, 2017, pp.37, 705~711
- White WB, "Cardiovascular safety of febuxostat or allopurinol in patients with gout", N Engl J Med, 378, pp.1200~1210 (2018)[DOI]
- Zhang M, "Assessment of cardiovascular risk in older patients with gout initiating febuxostat versus allopurinol: a population-based cohort study", Circulation (2018)